Skip to contentApplication 202415
- Type
- ANDA
- Sponsor
- ACTAVIS ELIZABETH
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DONEPEZIL HYDROCHLORIDE | DONEPEZIL HYDROCHLORIDE | TABLET;ORAL | 23MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0228-4529 | Donepezil hydrochloride | Donepezil hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 0228-4529 | Donepezil hydrochloride | Donepezil hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 0228-4529 | Donepezil hydrochloride | Donepezil hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 0228-4529 | Donepezil hydrochloride | Donepezil hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 0228-4529 | Donepezil hydrochloride | Donepezil hydrochloride | Actavis Pharma, Inc. | ANDA | Current |